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Spondylocostal dysostosisionarily conserved mechanism that determines cell fate in a variety of contexts
during development. This is achieved through different modes of action that are context dependent. One
mode involves boundary formation between two groups of cells. With this mode of action, Notch signaling is
central to vertebrate evolution as it drives the segmentation of paraxial mesoderm in the formation of
somites, which are the precursors of the vertebra. In this case, boundary formation facilitates a mesenchymal
to epithelial transition, leading to the creation of a somite. In addition, the boundary establishes a signaling
center that patterns the somite, a feature that directly impacts on vertebral column formation. Studies in
Xenopus, zebraﬁsh, chicken and mouse have established the importance of Notch signaling in somitogenesis,
and indeed in mouse how perturbations in somitogenesis affect vertebral column formation. Spondylocostal
dysostosis is a congenital disorder characterized by formation of abnormal vertebrae. Here, mutation in
Notch pathway genes demonstrates that Notch signaling is also required for normal somite formation and
vertebral column development in humans; of particular interest here is mutation of the LUNATIC FRINGE
(LFNG) gene, which causes SCD type 3. LUNATIC FRINGE encodes for a fucose-speciﬁc β1,3-N-
acetylglucosaminyltransferase, which modiﬁes Notch receptors and alters Notch signaling activity. This
review will focus on Notch glycolsylation, and the role of LUNATIC FRINGE in somite formation and vertebral
column development in mice and humans.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionAbnormal vertebral segmentation (AVS) is a common congenital
abnormality that affects vertebra singly or in multiples. AVS results in
a variety of morphologies that affect vertebral size, shape and
integrity; these ultimately impact upon the shape and ﬂexure of the
spine. AVSmay represent an isolated ﬁnding or, in the case of multiple
AVS is commonly associated with a range of dysmorphic features. In
only a small proportion of AVS cases has the genetic component been
identiﬁed (reviewed in [1]). Spondylocostal dysostosis (SCD) repre-
sent one of these cases, with mutation in genes of the Notch signaling
pathway, segregating with this disorder with a recessive mode of
inheritance. Loss of functionmutations in genes of the Notch signaling
pathway in mouse have demonstrated the essential role that Notch
signaling plays in the formation of the vertebral column and in its
precursor, the somites. Somite formation occurs in a reiterative
manner during embryonic development, and studies in a number of
vertebrate species have lead to the elucidation of numerous
components of the Notch signaling pathway that function in somite
formation (reviewed in [2]). Notch signaling is instrumental in two
aspects of somitogenesis; segmentation of discrete somites fromll rights reserved.unsegmentedmesenchyme and rostrocaudal patterning of the somite.
Disruption of either of these processes has a profound impact on the
vertebral column (reviewed in [3]).
2. Notch signaling and pathway components
2.1. Mechanisms of action
The Notch signaling pathway instructs developmental processes
using different mechanisms of action described as lateral inhibition/
speciﬁcation, inductive signaling and boundary formation. Lateral
inhibition/speciﬁcation occurs between largely “equivalent” groups of
cells that express both Notch receptor and ligand. Notch signaling
ampliﬁes small differences between these cells until distinct bio-
chemical events occur that dictate cell fate, and results in the
generation of cells of different types. Lateral inhibition/speciﬁcation
is instrumental in neurogenesis in vertebrates and invertebrates
(reviewed in [4–6]). Inductive signaling occurs between non-equiva-
lent cells and despite expression of both ligand and receptors in both
populations, signaling occurs directionally to alter cell fate. Lympho-
poiesis is perhaps the best-characterized example in vertebrates. Here,
despite the fact that Notch receptors and ligands are expressed in both
bone marrow progenitors and the thymic stroma, Notch1 signaling
occurs in bone marrow progenitors and is required for their
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signaling in boundary formation is the most relevant to this review;
here, Notch facilitates the formation of borders between distinct
cellular ﬁelds. Examples of this exist in disparate developmental
contexts; establishment of the dorsoventral wing boundary and the
equator in the eye (Drosophila), anteroposterior border formation of
the boundary between the dorsal and ventral thalamus (chicken), in
rhombomeric boundary function of the hindbrain (zebraﬁsh), and in
segmentation of developing somites (Xenopus, snake, zebraﬁsh,
chicken, mouse [10–12]) (reviewed in [13,14]).
Somite formation, like embryonic development in general, is
reliant on the activity of a number of key signaling mechanisms to
drive fundamental processes such as cell proliferation, apoptosis, fate
decisions, differentiation and migration. The complexity of the task is
contingent on the integration of these processes and the signaling
pathways that drive them. The Notch signaling pathway is known to
integrate with ﬁbroblast growth factor (FGF), hedgehog (Hh), janus
kinase/signal transducers and activators of transcription (Jak/STAT),
receptor tyrosine kinase (RTK), transforming growth factor-β (TGF-β),
Wnt, and hypoxia pathways [15] (reviewed in [2,16]). The degree of
integration between these signaling pathways and Notch has not been
fully realized and the subject of future research will be to unravel
these interdependencies.
2.2. Notch receptor and signal transduction
The Notch signaling pathway, ﬁrst identiﬁed in Drosophila, is
largely conserved through evolution from invertebrates to vertebrates
[17,18]. Notch is a type I transmembrane receptor that exists on the cellFig. 1.Mammalian Notch receptors and DSL ligands. The 4 Notch receptors (Notch1–4) and
with their carboxy terminus in the cytosol. Notch receptors: N-terminal to the transmembr
that are required for ligand binding, three LIN12/Notch repeats (LNR) that prevent ligand
which contains the S2 cleavage site. C-terminal to the transmembrane domain the receptor
(ANK) repeats which generally moderate protein interactions and are hydroxylated by facto
RAM domain and Notch1–3 have a second NLS. There is a transcription activation domain (T
residues (PEST) that is associated with protein degradation. A TAD has not been identiﬁed in
terminal to the transmembrane domain, the DLS ligands (excluding Dll3) have a Delta/Serr
Notch. Jagged1–2 have a von Willebrand factor type C domain (VWC) which is generally
proteins are unstructured and, excluding Dll3 and Jagged2, there is a PDZ ligand-binding
ExPASy http://www.expasy.org/sprot/, SMART http://smart.embl-heidelberg.de/, PESTﬁn
webtool.htm, [160–167].surface as a heterodimer [19,20]. The receptor is activated upon
binding delta or serrate, also type I transmembrane proteins, resident
on adjacent cells. This activation of the signaling pathway in trans
results in the signal-receiving cell often adopting a different fate to
that of the signal-sending cell. In mammals, there are four Notch
receptors (Notch1–4) (Fig. 1). The extracellular domains of Notch
contain between 29 and 36 EGF-like repeats, associated with ligand
binding, and three Lin-12/Notch (LIN) repeats that prevent ligand-
independent signaling. The intracellular domain contains two protein
interaction domains: the RBPj associated molecule (RAM) domain
binds RBPj/CSL, and six ankyrin (ANK) repeats moderate protein
interactions. Nuclear localization signals (NLS), a transactivation
domain (TAD), and a PEST sequence, are also present to various
extents.
The Notch signaling pathway is deceptively simple, it lacks second
messengers as the intracellular domain (ICD) of the Notch receptor
participates directly in target gene transcription (Fig. 2). However it is
becoming increasingly clear that signaling speciﬁcity brings complex-
ity and this is achieved through the action of Notch signalingmodiﬁers
(reviewed in [18]). Notch is synthesized as a single polypeptide.
Speciﬁc epidermal growth factor (EGF)-like repeats aremodiﬁed byO-
fucosylation in the endoplasmic reticulum (ER) by protein O-
fucosyltransferase 1 (Pofut1). As Notch trafﬁcs through the Golgi, it
may be further modiﬁed by elongation of the O-linked fucose with an
N-acetylglucosamine (GlcNAc); this is catalysed by a fucose-speciﬁc
β1,3-N-acetylglucosaminyltransferase (β1,3-GlcNAc-transferase;
fringe) [21,22]. In the trans-Golgi network, Notch is cleaved (S1
cleavage) by a furin-like convertase [19,20]. The N-terminal extra-
cellular truncation (ECN) and C-terminal transmembrane and5 DSL ligands (Dll1, Dll3, Dll4, Jagged1 and Jagged2) are type I transmembrane proteins
ane domain, Notch receptors have 29 to 36 epidermal growth factor (EGF)-like repeats
-independent signaling, and a heterodimerisation domain (overlapping parallel lines)
s have an RBPj associated molecule (RAM) domain that binds RBPj/CSL, and six ankyrin
r inhibiting HIF (FIH) in Notch1–3. There is a nuclear localization sequence (NLS) in the
AD), and a C-terminal polypeptide enriched in proline, glutamine, serine and threonine
Notch3 or Notch4. Notch4 also lacks a second NLS and PEST sequence. DSL Ligands: N-
ate/Lag (DLS) domain and EGF-like repeats that interacts with the EGF-like repeats of
involved in multiprotein complexes. C-terminal to the transmembrane domain the
domain (PDZLDB) at the C-terminus. This ﬁgure was assembled using the following:
d Analysis Webtool https://emb1.bcc.univie.ac.at/toolbox/pestﬁnd/pestﬁnd-analysis-
Fig. 2. Notch1 signaling in mammalian somitogenesis. Notch1 is synthesized as a single polypeptide. (A) Speciﬁc EGF-like repeats are modiﬁed by O-fucosylation in the endoplasmic
reticulum (ER) by protein O-fucosyltransferase 1 (Pofut1). As the Notch1 polypeptide passes through the Golgi, these O-fucosylated EGF-like repeats may undergo elongation with
the addition of GlcNAc by lunatic fringe (Lfng). (B) S1 cleavage by a furin-like convertase occurs in the trans-Golgi network (TGN). Unlike Dll1, the divergent ligand Dll3 is located in
the cis-Golgi and not at the cell surface. (C) The Notch1 heterodimer consisting of the N-terminal extracellular truncation (ECN) and C-terminal transmembrane and intracellular
domain (TMIC) trafﬁcs to the cell surface. (D) The DSL ligand Dll1 binds Notch1 ECN in trans and activates S2 cleavage by the disintegrin and metallopeptidase domain (ADAM)
proteases ADAM10 or ADAM17. (E) This releases Notch1 ECN, which binds to Dll1, is trans-endocytosed into the signal-sending cell. (F) The membrane anchored Notch1 extracellular
truncation (EXT) may undergo ubiquitylation (ub) facilitating endocytosis. Notch1 EXT undergoes S3 cleavage in the transmembrane domain, this is mediated by γ-secretase and
releases Notch1 ICD. (G) Notch1 ICD binds the DNA-binding protein CSL, this triggers the release of corepressor (CoR) proteins and histone deacetylases (HDACs), and facilities the
binding of coactivators (CoA) which results in transcription of target genes such as Mesp2, Lfng and Hes7. [18,19,168,169].
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non-covalent interactions and trafﬁc to the cell surface [23,24]. Here,
the ECN is available to interact with ligand in trans. Ligand binding
results in proteolytic cleavage (S2 cleavage) by disintegrin and
metalloprotease domain (ADAM) proteases ADAM10 and ADAM17,
and in the separation of the Notch heterodimer through trans-
endocytosis of the ECN into the signal-sending cell [25–30]. This
produces a transmembrane bound fragment with the extracellular
truncation (EXT), which is subsequently cleaved (S3 cleavage) by the
γ-secretase complex [31–33] resulting in the release of the Notchintracellular domain (ICD). Notch ICD translocates to the nucleus
where it forms a complex with the DNA-binding protein Rbpj/CSL
(CBF1-Suppressor of Hairless-Lag1) [34,35]. The interaction between
ICD and CSL leads to displacement of transcriptional co-repressors
previously complexed with CSL [34,36–39]. Mastermind-like (MAML)
is recruited to the Notch ICD-CSL complex ([40,41], engages proteins
required for transcriptional activation such as the histone acetyl-
transferase p300, and activates Notch target genes [37,42,43]. MAML
also recruits CycC:CDK8 (cyclinC: cyclin dependent kinase8) to this
binary complex, which leads to Notch ICD phosphorylation and
Fig. 3. O-linked glycosylation sites of mouse Notch1 EGF-like repeats. EGF-like repeats
that contain consensus sites for O-linked fucose (blue), O-linked glucose (yellow), or
both (green) are indicated. Identiﬁed O-fucose glycans include sialic acidα(2,3)
Galβ(1,4)GlcNAcβ(1,3)Fuc-O and O-glucose glycans include Xylα(1,3)Xylα(1,3)O-Glc-O.
The N-terminus of Notch1 is at the top. Standardized symbols and colors were used
from the Consortium for Functional Glycomics to represent glycans. [73,74,170].
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of the hairy/enhancer-of-split (HES), HES-related (HERP) and MESP
families of bHLH transcription factors, Lfng, Cyclin D1, p21WAF1, Nodal,
PTEN and GFAP [45–54].
2.3. DSL ligands trans-activate and cis-inhibit Notch signaling
Notch receptors bind DSL (Delta/Serrate/Lag2) ligands. In mam-
mals there are ﬁve DSL ligands that can be grouped into two classes
(Delta-like and Serrate-like) based on homology to Drosophila Delta or
Serrate. Dll1, Dll3 and Dll4 are Delta-like while Jagged1 and Jagged2
are Serrate-like ligands (Fig. 1). The extracellular domain is character-
ized by a signal peptide, an amino-terminal domain (with limited
homology between different DSL ligands), a DSL domain and a series
of EGF-like repeats [55]. C-terminal to the transmembrane domain is
an intracellular region lacking any recognizable motifs except for a
PDZ ligand-binding domain present in Dll1, Dll4 and Jagged1.
The DSL domain is related to an EGF-like repeat and is required for
receptor binding in trans. Relative afﬁnities of DSL ligands binding in
trans with Notch receptors have not been exhaustively determined;
however, it is known that Dll1 interacts with Notch1 and Notch2,
Jagged1 with Notch1-3, and Jagged2 with Notch2 [56–60]. Despite the
absence of recognizable motifs in the intracellular domain of DSL
ligands, this region is required to activate Notch in trans. It facilitates
endocytosis of the ligand in association with the ECN part of Notch,
into the ligand-expressing cell [27,28,61,62]. This endocytosis requires
the intracellular region of the DSL ligand to be ubiquitylated; this is
achieved through the action of two E3-ubiquitin ligases, Mindbomb
and Neuralized [63–65].
In addition to DSL ligands trans-activating Notch, they can also
inhibit signaling when expressed in the same cell (in cis) as Notch
[66,67]. When coexpressed, Notch1 interacts with Dll1 or Jagged1 not
on the cell surface but inside the cell [57]. The mechanism through
which this occurs is not known, however co-expression of Lfng (β1,3
N-acetlyglucosyltransferase) inhibits this cell autonomous interaction
[57]. Recently it has been shown that the DSL ligand Dll3 is distinct; it
does not trans-activate Notch but rather interacts with Notch only in
cis to inhibit signaling, and it is predominantly expressed in the cis-
Golgi [68,69].
3. Notch and DSL ligands are modiﬁed by glycosylation
3.1. O-glycosylation of Notch
The N-terminal region of Notch receptors contain tandem EGF-like
repeats that are small protein domains of 40 amino acids with six
conserved cysteines that form three conserved disulﬁde bonds [70].
EGF-like repeats are of two types: human EGF-like (hEGF) and
complement Clr-like (cEGF) [71]. The EGF-like repeats of Notch are the
hEGF type and this subtype is present in proteins that are shed from
the cell surface and mediate intercellular signaling [71]. Speciﬁc EGF-
like repeats of Notch undergo O-linked glycosylationwith the addition
of O-glucose and O-fucose (Fig. 3). These modiﬁcations occur on the
hydroxyls of serine or threonine residues in the EGF-like repeats; O-
glucose sites are located between the ﬁrst and second conserved
cysteine residues (C1XSXPC2) and O-fucose sites between the second
and third conserved cysteine residues (C2X4-5S/TC3) [72,73]. Both O-
glucose and O-fucose can be elongated by the sequential action of
other glycosyltransferases to yield a trisaccharide or a tetrasaccharide,
respectively (Fig. 3). The structure, based on other EGF-associated O-
glucose trisaccharide, is predicted to be Xylα1,3Xylα1,3Glc (where Xyl
is xylose and Glc is glucose, inwhich glucose is attached to serine [74].
The tetrasaccharide attached to Notch is Sia-α2,3/6-Gal-β1,4-GlcNAc-
β1,3-Fuc-α1-O-Ser (where Sia is sialic acid, Gal is galactose, GlcNAc is
N-acetylglucosamine and Fuc is fucose, in which fucose is attached to
serine or threonine [74].O-glucosyltransferase activity using an EGF-like repeat as the
acceptor and UDP-[(3)H]glucose as the donor was identiﬁed in
mammalian cells and tissues; however, the gene encoding this activity
was not identiﬁed [75]. Only recently, a genetic screen designed to
isolate temperature-sensitive mutants of Drosophila that affected
Notch signaling identiﬁed rumi, a mutant that completely lacks O-
glycosyltransferase activity [76]. The rumi gene encodes a CAP10
domain protein O-glycosyltransferase that acts in the endoplasmic
reticulum (ER) lumen to regulate Notch folding. In the absence of
rumi, the ability of Notch to be expressed on the cell surface and to
bind Delta is not impaired, however S2 cleavage of Notch does not
occur. This suggests that O-glucose modiﬁcation by rumi is required
for the ligand-induced conformational change that is required for S2
cleavage of Notch in Drosophila.
O-fucosyltransferase catalyses the addition of O-fucose to serine
and threonine residues of Notch EGF-like repeats (Ofut1 in Drosophila
and Pofut1 in mammals). In Drosophila, loss of Ofut1 phenocopies the
loss of fringe and indicates that the absence of O-fucose is equivalent
to the absence of elongated O-fucose. In mouse loss of Pofut1 conﬁrms
that O-fucosyltransferase activity is essential for Notch function;
however, the phenotype is more similar to that generated when
Notch signaling is blocked through, for example, the loss of RBPj/CSL
[74,77–80]. While most fucosyltransferases are type II membrane
proteins in the trans-Golgi, Ofut1/Pofut1 is a soluble protein in ER
[81,82]. Functions for Ofut1, independent of, and dependent on trans-
ferase-activity, have been proposed that include folding of Notch in
the ER, endocytic trafﬁcking of Notch, and Notch-ligand binding
[78,79,82–84]. Recent evidence provides compelling support for the
non-catalytic activity of Ofut1 as a regulator of Notch trafﬁcking to the
cell surface, probably through action as a chaperone in the ER to
promote the proper folding of the extracellular domain of Notch [85].
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Notch receptor activity and led to phenotypes mimicking loss of fringe
activity (see below) [85]. In contrast to Drosophila Ofut1, mammalian
Pofut1 is required for the generation of optimally functional Notch
receptors, but is not an essential chaperone for stable, cell surface
expression of Notch receptors [86].
3.2. Fringe elongates O-fucose of Notch EGF-like repeats
Fringe was identiﬁed in Drosophila as a gene that affected formation
of the dorsoventral boundary during wing formation [87]. Genetic
analysis revealed that fringe potentates delta-dependent Notch signal-
ing and inhibits serrate-dependent Notch signaling [21,22,88,89]. Fringe
encodes a fucose-speciﬁc β1,3-N-acetylglucosaminyltransferase (β1,3-
GlcNAc-transferase). Fringe activity requires UDP-GlcNAc as a donor and
O-linked fucose in the alpha conformation as an acceptor [89]. In
mammals, three genes encode for fringe activity; lunatic fringe (Lfng),
manic fringe (Mfng) and radical fringe (Rfng) each of which is capable of
complementing mutations in Drosophila fringe (Dfng) [90,91]. Fringe
shows considerable preference for a properly folded EGF-like repeat as a
substrate, and can glycosylate EGF-like repeats on Notch receptors and
DSL ligands [74,75,88,92].
3.3. Mammalian fringe proteins
3.3.1. Catalytic activity
The catalytic activity of fringe proteins has been compared, and
despite the use of different acceptor substrates, Lfng has a signiﬁcantly
higher catalytic efﬁciency thanMfng, Rfng or DLfng [89,93]. Given that
the substrate greatly affects the measured catalytic activity of the
fringe enzymes, the current picture of relative activity may not be
representative of speciﬁc fringe–notch interactions. Indeed, not all O-
fucosylated EGF-like repeats are modiﬁed by Fringe, suggesting that
Fringe may recognize amino acid sequences in individual EGF-like
repeats [73]. Of those O-fucose EGF-like repeats that are modiﬁed by
fringe activity, the three mammalian fringes display similar speciﬁcity
with regard to the EGF-like repeats that aremodiﬁed [93]; distinctions
have been reported, with Mfng showing the least ability to modify O-
fucose EGF-like repeats, but it is currently unclear if these are due to
differences in catalytic activity of the fringes, or substrate recognition
[88,90].
3.3.2. Impact on Notch signaling
The three mammalian fringes have the capacity to modify four
receptors; therefore, the effects of fringe activity on Notch signaling in
mammals are more complex and not yet fully understood. Generally
speaking, as in Drosophila, fringe activity enhances delta-mediated
Notch signaling and inhibits jagged-mediated Notch activity [56,94].
Current exceptions are: Rfng potentiates Jagged1-mediated Notch1
signaling [94]. Mfng does not enhance Notch2 signaling [95], and Lfng
potentiates Jagged1-mediated Notch2 signaling [56]. These data are
incomplete and further uncertainty ensues when gain-and loss-of-
function studies with Lfng in chick and mouse embryos conclude that
Lfng inhibits Notch1 signaling [96–98].
Fringe activity alters the efﬁcacy of Notch-ligand binding in trans
to affect Notch signaling [56,88,94]. Fringe activity increases the
capacity of Notch1 to bind to Dll1 but does not alter Notch1-Jagged1
binding [94]. These binding assays relied on in vivo glycosylation so
it was unclear if further modiﬁcation of Notch, subsequent to the
addition of GlcNAc by fringe, affected Notch-ligand binding. In vitro
reconstitution assays demonstrated that addition of GlcNAc by fringe
is sufﬁcient to alter the interaction of Notch with its ligands, and
that further elongation of the GlcNAc-1,3-Fuc disaccharide by Gal did
not alter Notch-ligand binding in vitro [99]. In contrast, Chen et al.
[100,101] showed that Fringe modulation of Jagged1-induced Notch
signaling requires the addition of Gal to form the trisaccharide O-Fuc-GlcNAc-Gal on Notch. A deﬁnitive role for Fuc-GlcNAc-Gal in
somitogenesis has not been shown as embryos lacking β4galacto-
syltransferase-1 (β4GalT-1) have morphologically normal somites,
but this is likely to be due to redundancy as several B4galt genes are
expressed in the embryo [101]. These disparate ﬁndings may reﬂect
the fact that binding of Drosophila ligands with Notch was assayed
in one study [99], and Notch signaling in rodent cells was examined
in the other [100].
As previously discussed, Notch receptors and DSL ligands also
interact in cis leading to inhibition of signaling [57,68,69]. Expression
of Lfng inhibits the intracellular interaction of Notch1 with Dll1 or
Jagged1 [57] but not with Dll3 [69]. The mechanism of ligand-
dependent cis-inhibition of Notch signaling, and the role of fringe
activity in this inhibition, is unknown.
4. Spondylocostal dysostosis (SCD) is caused by mutation of the
fucose-speciﬁc β1,3 N-acetylglucosaminyltransferase LFNG
4.1. Spondylocostal dysostoses are a group of vertebral malsegmentation
disorders
The vertebral column is characterized by the linear arrangement of
regularly shaped vertebrae, bound together and supported by tendons
and muscles. The vertebrae, tendons and muscles of the axial skeleton
all differentiate from somites, which are derived from mesoderm.
Somites condense into epithelial spheres on either side of the
embryonic midline in a reiterative manner from caudally located
presomitic mesoderm (PSM) during embryonic development. The
ventral half of the somite (sclerotome) reverts to mesenchyme, which
migrates around the neural tube and notochord and becomes
partitioned into rostral and caudal halves; the caudal half of one
somite combines with the rostral half of its neighboring somite to
form an individual vertebra. These mesenchymal cells differentiate
into cartilage, which later ossiﬁes forming deﬁnitive vertebrae. These
aspects of somite patterning and vertebral column formation have
been well reviewed [102–104]. Abnormal vertebral segmentation
(AVS) is a common congenital abnormality with an estimated
prevalence of 0.5–1/1000 [105–108]. Many manifestations of AVS
exist resulting in uneven or fused vertebrae that can be present once
in the vertebral column or in multiples; AVS follows Mendelian
inheritance (autosomal dominant and recessive) and also can occur
sporadically [1]. The term spondylocostal dysostosis (SCD) is applied
to a wide variety of radiological features that include multiple AVS.
These include contiguous involvement of greater than ten vertebrae,
often affecting all spinal regions. Despite asymmetric misalignment of
some ribs and the presence of rib fusions, there is a basic overall
symmetry to the shape of the thorax. Individuals with SCD have
reduced stature and nonprogressive kyphosis [1]. Genetic mapping
and candidate gene sequencing approaches have identiﬁed causative
mutations in four genes. SCDO1 (OMIM 277300) [109] represents
around 20% of all cases, and is due to mutation of the DLL3 gene, with
25 distinct causative mutations identiﬁed to date [109–112] and
unpublished). Mutation inMESP2 (SCDO2; OMIM 608681 [113]), LFNG
(SCDO3; OMIM 609813 [114]) and HES7 (SCDO4; [115]) appear to
occur less frequently as they are currently represented by single cases.
All four genes are part of the Notch signaling pathway; DLL3 encodes
an inhibitory ligand of Notch and MESP2, LFNG and HES7 are Notch
target genes expressed in the PSM.
4.2. Mutation of LFNG cause SCDO3
The proband presented with extensive congenital vertebral ano-
malies (Fig. 4), long, slender ﬁngers, and camptodactyly of the left
index ﬁnger. Multiple vertebral ossiﬁcation centers in the thoracic
spine, with ﬁtted angular shapes were apparent. The severe
foreshortening of the spine was emphasized by the comparison of
Fig. 4. Vertebral anomalies caused by mutation of LFNG. Radiograph (A) and T2-weighted coronal MRI images (B, C) in the vertebral plane. (A) Severe vertebral segmentation
anomalies throughout the vertebral column. (B) Thoracic spine showing vertebral centers with a ﬁtted angular shape. (C) Cervical and lumbar spine showing similar segmental
anomalies. Reprinted from Sparrow et al [114], © 2005 by The American Society of Human Genetics.
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Sequence analysis did not identify mutations in DLL3 or MESP2;
therefore a candidate gene approach was used to identify the genetic
cause of SCD in this patient. A search for mouse mutants that
recapitulated the SCD phenotype suggested that LFNG was indeed a
good candidate for causing SCD. The phenotypes of embryos lacking
Dll3 and Lfng are virtually identical [116], indicating that murine
somitogenesis is similarly dependent on each gene. Moreover, Lfng
gene expression is severely disrupted in Dll3 null embryos, suggesting
that Lfng expression is dependent on Dll3 function [117,118]. A
homozygous missense mutation (c.564CNA) in exon 3 was detected,
resulting in the substitution of leucine for phenylalanine (F188L) [114].
The proband's consanguineous parents had normal spinal anatomy,
and were both heterozygous for the mutant allele. The substituted
phenylalanine residue is absolutely conserved in all known fringe
proteins from Drosophila melanogaster to humans [119] and is close to
the Mn2+-binding active site of the enzyme [100] which is DDD 200–
202 in human LFNG. Prediction of the structural consequence of the
F188L substitution, based on the highly homologous Manic Fringe
[120] suggests that the conserved phenylalanine residue (F188) is not
directly involved in uridine diphosphate (UDP)–GlcNAc (donor) or
protein binding. Rather, it is likely to reside in a helix that packs
against the strand containing theMn2+-ligating residues D200 and the
nearby D202. F188 is predicted to form an aromatic cluster with
residues F196 and H198, and thus the F188L mutation may either
cause steric perturbation of the Mn2+-binding site by altered packing
of the smaller mutant (leucine) residue or cause electronic disruption
of the enzymatic reaction by removal of required π–π interactions
associated with the aromatic ring [114].
Functional analysis of the LFNG F188L variant demonstrated that it
did not function like wildtype LFNG and thus it is considered that
c.564CNA in exon 3 represents a null mutation in LFNG [114]. Firstlylocalization of wildtype and F188L LFNG, was compared by expressing
wildtype mouse LFNG or the F187L, which is the mouse version of
F188L in C2C12myoblasts cells. LFNG is normally localized to the Golgi
where it adds β-1,3-N-acetylglucosamine to O-fucosylated EGF-like
repeats of Notch [56]. This was conﬁrmed with wildtype LFNG, it
accumulated in a Golgi-like pattern in the cell and colocalized with
GM130, which marks the cis-Golgi compartment. In contrast F187L
was neither enriched in a Golgi-like pattern nor was there colocaliza-
tionwith GM130. Next, the ability of LFNG to modify Notch1 signaling
was determined using a coculture assay [121]. Notch1 signaling is
enhanced by LFNG when trans-activated by the Dll1 ligand and
conversely attenuated when activated by the Jagged1 ligand [56,94]. It
was demonstrated that LFNG F187L did not enhance Dll1-Notch1
signaling and did not reduce Jagged1-Notch1 signaling like wildtype
LFNG. Finally the GlcNAc-transferase activity of F187L was examined
in vitro using UDP-[3H]GlcNAc as the donor and pNp-fucose as the
acceptor for the reaction; F187L lacked GlcNAc-transferase activity
[114].
In summary these studies demonstrate that F1887L did not
accumulate in the Golgi, did not modify Notch1 signaling, and lacked
GlcNAc-transferase activity. LFNG D202A was used as a control in
these assays as it lacks transferase activity [89,100]. F187L was
functionally equivalent to D202A except that D202A localized
normally to the Golgi [114]. These ﬁndings strongly support the
hypothesis that F188L is non-functional and causes SCD in this patient.
4.3. Lfng-null mice model SCDO3 and deﬁne the developmental origins of
the vertebral anomalies
4.3.1. Lfng expression in mouse
In mouse during gastrulation, Lfng transcripts are localized to
posterior nascent mesoderm with expression becoming restricted to
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coincident with Mesp2, implicating Lfng in head-trunk boundary
formation and demonstrating the existence of molecular prepattern-
ing in nascent mesoderm [118]. Later in the PSM, Lfng transcripts are
present in two domains; a broad caudal domain characterized by
oscillatory expression, and a rostral domain that narrows in synchrony
with somite formation (Fig. 5A). These two domains of Lfng expressionFig. 5. Cycling expression of Lfng. Dorsal views of whole-mount RNA in situ hybridization p
rostral at the top. (A) Cycling Lfng expression is represented in three phases at E9.5. Embryos h
Lfng expression in embryos, bisected into axial halves. The left half was ﬁxed, while the righ
shift, and caudal regions of expression also change. Arrowheads indicate rostral Lfng bands o
activities involved in Mesp2 activation and the subsequent events regulated by Mesp2.Mesp
and Notch1 signaling (NICD dotted line). The Notch1 signal oscillates in the presomitic m
generated, NICD is suppressed and several genes are activated that establish the segmental
somite; S-1, S-2, somite primordia. Asterisks show caudal presomitic mesodermal expressioare driven by distinct regulatory elements and the identiﬁcation of
functional CSL binding sites demonstrates that Lfng is a direct target of
Notch signaling [45,49]. Like Lfng, other targets of Notch signaling are
expressed in an oscillatory pattern in the PSM such as Hes1, Hes5,
Hes7, and Hey1 [117,123–126]; they oscillate in caudal PSM in phase
with the detection of Notch1 ICD which is the cleaved, activated form
of Notch1 [97,127]. Somitogenesis relies on the oscillatory progressionreparations of mouse embryo presomitic mesoderm showing Lfng expression (purple),
ave been arranged to display selected stages in the temporal sequence of expression. (B)
t half was cultured for 45 min. Rostral bands of Lfng expression display an anteriograde
f expression. Asterisks show caudal expression. (C) A schematic depiction of the genetic
2 is expressed in the anterior presomitic mesoderm by the cooperative function of Tbx6
esoderm, thus the dotted line moves anteriorly (white arrow). Once Mesp2 protein is
border and rostral–caudal polarity within the somites. S1, formed somite; S0, forming
n. Panels A, B are reproduced from Kusumi et al [118], and panel C from Saga et al [130].
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tory Notch1 activation is the cyclical expression of the transcriptional
repressor Hes7 (reviewed in [128]). Hes7, like Lfng, is a target gene of
Notch1 signaling; Hes7 protein inhibits its own transcription as well
as that of Lfng. These interdependent negative regulatory mechanisms
by Hes7 and Lfng are important to maintain the oscillatory activation
of Notch1 in the PSM. Recently Shiﬂey and Cole have demonstrated
that processing of the mouse Lfng preprotein reduces the half-life of
the enzyme, thus facilitating the rapid oscillations of Lfng activity and
the segmentation clock that drives somitogenesis [129].
In the rostral PSM Lfng expression is also activated by Mesp2, Lfng
then inhibits Notch1 signaling in this region creating an interface
between cells undergoingNotch1 signaling and cellswhich are not; this
interfacemarks the sitewhere the next somite boundarywill form (Fig.
5C) [97]. In addition, the rostral PSM cells that express Lfng adopt a
rostral fate due to co-expression with Mesp2; Mesp2 acts as a rostral
determinant as it restricts the expression of the caudal determinant,
Dll1 to the caudal half-somite [97,130,131] (Fig. 5B). The expression of
Lfng is altered in the PSMofNotchpathwaymutants; further supporting
the ﬁnding that Lfng is a target of Notch signaling [117,118,132,133].Fig. 6. Skeletal phenotype of Lfng-null mice. (A) Photograph of 8-week-old wild-type and m
shortened from the neck to the rump. (B–E)Alcian blue/Alizarin red skeletal preparations of ne
homozygous mutant). (C) Dorsal and ventral views of the cervical, thoracic and lumbar regio
Reprinted by permission from Macmillan Publishers Ltd: Nature, Evrard et al [150], copyrighIn addition to its expression in the PSM, Lfng is expressed in a
number of other locations in the embryo and postnatal mouse, these
include: the segmenting hindbrain, ventricular zone of the developing
cortex neural crest cells, olfactory placode, inner ear, lung, kidney,
urogenital epithelium and prostate, ovary, thymus and developing T
cells, small intestine skin, hair follicle and teeth [90,91,133–149].
4.3.2. Somitic defects in mouse
Lfng is the only mammalian fringe protein required for normal
somitogenesis [116,150,151]. Lfng-null mice have a reduced viability at
birth and before weaning; their shortened tail consists of few
vertebrae and their body is truncated (Fig. 6). The axial skeleton of
these mice is severely disrupted along its length consisting of hemi-
vertebrae, and fusion of vertebrae, neural arches and ribs. These
skeletal defects are presaged by anomalies in their precursor tissues,
the somites. Somites are divided and patterned in order to impart
ﬂexibility and regularity on the components of the vertebral column,
in addition they instruct the position of the dorsal route ganglia and
the trajectories of the spinal nerves. Cells of the sclerotome condense
in the caudal half of each somite and in doing so restrict the passage ofutant littermates. Mutant animals have a very small and bent tail and their body axis is
wbornwild-type andmutantmice. (B) Side viewwith limbs removed (WT,wild type;−/−,
ns, with the ventral ribs and sternum removed. (C) Dissected ventral ribs and sternum.
t (1998).
108 S.L. Dunwoodie / Biochimica et Biophysica Acta 1792 (2009) 100–111neural crest cells and spinal nerve axons through the rostral part of the
somite (reviewed [152]). In the absence of Lfng, the normal alternating
density of sclerotome and the regular spacing of dorsal route ganglia
and spinal nerve axons are disrupted. These defects are highly
reminiscent of those generated when other components of the
Notch signaling pathway, such as Dll3, Mesp2, Hes7 and Rippley2, are
absent during mouse development [117,123,153,154]. Lfng is a direct
target of Notch, and as already noted Lfng inhibits Notch signaling in
the PSM of mouse and chick embryos [96–98]. It is therefore
consistent with this that Notch1 signaling is disrupted in the PSM of
Lfng-null embryos and accordingly so is the expression of other
known targets of Notch (Mesp2, Hes5) [97,150]. More recently in an
effort to dissect further the roles of Lfng in somitogenesis Shiﬂey et al.
[98] deleted the oscillatory expression of Lfng, leaving the gene
regulatory elements that control expression in the rostral PSM. In the
absence of oscillatory Lfng expression in the caudal PSM, Notch1
activation does not cycle and instead is widespread. In addition, the
mice developed AVS in the thoracic and lumbar spine, while the sacral
and tail vertebrae are only minimally affected. This indicates that
oscillatory Lfng expression and activation of Notch1 are necessary for
normal segmentation and patterning of somites in the thoracic and
lumbar regions, and largely dispensable during formation of the more
caudal somites.
Whilst defects in somitogenesis and vertebral column formation
are the most striking in mice lacking Lfng, functions for Lfng have also
been uncovered in the inner ear and ovary. Lfng is expressed in non-
sensory supporting cells in the mouse cochlea [140] and whilst
deletion of Lfng has no effect on hair cell number or pattering, loss of
Lfng does suppress the production of supernumerary hair cells that
arise in the absence of the Notch ligand Jagged2 [149]. In addition,
Lfng is expressed in the granulosa cells of the developing ovarian
follicles and in its absence folliculogenesis is abnormal with the
progression of oocytes through slow and incomplete meiosis [136].
Infertility may be variable in its penetrance as some Lfng-null females
are reportedly fertile [155].
5. Conclusions and perspectives
There has been incredible progress made as many of the genetic
effectors of somitogenesis have been elucidated. Prominent in this
increased understanding is the Notch signaling pathway, and the
uncovering of the role that it plays in somite formation and patterning.
The fucose-speciﬁc β1,3-N-acetylglucosaminyltransferase Lfng
emerges as a prominent component of Notch1 signaling in the PSM
and there is now an understanding of interdependency between
target genes of Notch signaling, such as Hes7 and Lfng, and the
oscillatory activity of the Notch1 receptor in the PSM. In addition in
the rostral PSM there is an understanding of how the transcription
factor Mesp2 controls Lfng expression, and in doing so narrows the
region of Notch1 signaling in the rostral PSM; this is providing great
insights into the processes of somite segmentation and pattering. It is
still not clear how Lfng expression leads to inhibition of Notch1 in the
PSM, as in vitro studies show that Lfng potentiates Notch1 signaling
when the receptor is trans-activated by the Dll1 ligand. Since Dll1 is
the activating ligand of Notch1 in the PSM one might expect Notch1
activity to be potentiated by Lfng. It is clear that an understanding of
Lfng modiﬁcation of Notch1 ligands, and its potential role in ligand-
dependent cis-inhibition of Notch1 will need to be achieved in order
to address this conundrum.
Interaction between Notch signaling components and FGF andWnt
signaling are clearly important for somiogenesis [156–158] (reviewed
in [2]). Effort is being made to establish a hierarchy between FGF,
Notch and Wnt signaling in the PSM; this may be difﬁcult to fully
appreciate given the degree of negative feedback mechanisms that
bind these pathways together. It is indeed this interdependency that
likely underpins the robustness of somitogenesis.Themouse has been at the forefront of research into somitogenesis
as genetic modiﬁcation has enabled deﬁnitive roles for many genes to
be established (reviewed in [2,159]). Clinical research into the genetic
causes of AVS has clearly beneﬁted from these developmental genetic
studies inmice. For example, the discoveries showing that mutation of
DLL3, MESP2, LFNG and very recently HES7, cause the congenital AVS
disorder SCD were underpinned by the ﬁndings that these genes are
each required for somite formation in mouse. Genetic analysis in
mouse has shown that Notch, FGF and Wnt signaling are central to
somitogenesis, therefore components of these pathways represent
candidate genes for causing SCD (independent of DLL3, MESP2, LFNG
or HES7) as well as other AVS disorders.
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